From Months to Minutes: AI-Driven Ingredient Intelligence Revolutionizing OTC Drug Discovery

After facing costly delays and fragmented research cycles, a leading pharmaceutical company partnered with us to develop a next-generation ingredient discovery platform designed to streamline the development of OTC (Over-the-Counter) drugs. The company had a clear business vision: to transform drug sourcing and formulation by targeting underutilized, low-risk ingredients. The objective was to identify safe, underutilized drug ingredients through market, clinical, and regulatory intelligence. Our team at NextGen Invent collaborated closely to architect and develop the platform, equipped with AI-driven ingredient intelligence, classification models, automated data pipelines, and centralized dashboards. This platform unified disparate sources, from FDA regulatory datasets to market activity monitors, into a single, cohesive intelligence hub.

Today, this solution has helped our client slash R&D timelines, gain a competitive advantage in ingredient sourcing, and rapidly expand their product pipeline into OTC pharmaceuticals.

The client is a transformative pharmaceutical company with a mission to enhance patient care by delivering affordable, high-value medications addressing unmet clinical needs. They specialize in identifying and commercializing safe, effective pharmaceutical products by leveraging business intelligence and data-driven product discovery methods. With a unique market approach focused on reducing regulatory friction, the company seeks to optimize OTC drug formulation by targeting well-established yet underutilized ingredients.

90 Mins Reduced Screening Time ↓

24x Faster Increased Screening Speed↑

Industry

Life Sciences (Pharmaceutical Manufacturing)

Business Problem

Broken Data Plumbing: Teams had to manually extract and cross-verify ingredient information across multiple unconnected sources, such as: FDA, the FDA Orange Book, clinical trial data, trademark repositories, and market activity trackers, leading to lengthy and error-prone research cycles.

Time-Intensive Ingredient Identification: The absence of intelligent automation resulted in R&D teams spending 3–4 months manually validating potential drug ingredients across regulatory, clinical, and market datasets, creating bottlenecks in screening speed and stalling product pipeline growth.

Missed OTC Opportunities:Without proactive identification of “orphan” drugs (ingredients with limited market presence), the company struggled to identify underutilized, low-competition ingredients, resulting in missed chances to rapidly commercialize unique, high-value OTC products with minimal market competition.

High Risk of Trademark Conflicts: Manual verification processes to check ingredient-related trademark availability were cumbersome and increased the risk of conflicts at late stages of product commercialization.

Solution Approach

Unified AI-driven Ingredient Intelligence Platform: We engineered a robust platform that integrated data from sources such as: FDA, Orange Book, DrugBank, USPTO trademark databases, and other regulatory sources, providing a single point of truth for ingredient research and selection.

Off-Label & OTC Classification AI Model: Developed and deployed AI-powered classification models that automatically distinguish between prescription and OTC drugs, including off-label use indicators, enabling rapid decision-making on formulation pathways.

Automated Orphan Ingredient Discovery: Created automated pipelines connecting Analysource and market sales datasets to instantly identify orphan ingredients, uncovering low-competition, high-opportunity candidates, and accelerating their evaluation for rapid entry into the OTC drug market.

Trademark Conflict Detection: Deployed automated USPTO data pipelines that continuously monitor for trademark ownership conflicts, empowering early-stage identification of legal risks, preventing costly product reworks, and safeguarding commercialization processes from late-stage disruptions.

Book a Free Consultation

Value Delivered

Our end-to-end ingredient intelligence solution transformed the client’s OTC drug development lifecycle, reducing ingredient screening time from 3–4 months to just 90 minutes. The centralized platform eliminated manual data hunting, minimized human error, and unlocked unprecedented agility in bringing OTC formulations to market.

With AI-powered classification and automated market analysis, the company now confidently identifies low-risk, high-potential ingredients faster than ever, accelerating R&D and reducing time-to-market. Seamless access to regulatory, clinical, and commercial intelligence ensures informed decisions, enabling pipeline expansion with reduced overhead. By replacing fragmented workflows with a cohesive ingredient discovery engine, we empowered the client to build a scalable, data-backed approach to OTC drug development, setting new benchmarks in pharmaceutical innovation speed and efficiency.

Our Case Study

Gen AI-Driven Decision Engine brings Innovations to Consumer Product Testing

The Gen AI-driven decision support engine transforming consumer product testing by introducing a seamless, intelligent process from ideation to product launch. It integrates feedback channels, customer surveys, activity logs, and performance heatmaps, providing actionable insights that enhance product design and development with precision.

→

Proteomics Research and Mass Spectrometry Research: Advanced Analytics Solution

Proteomics research is critical for driving breakthroughs in cancer research, neurology, and precision medicine, enabling the development of effective therapies and early disease diagnosis. Our advanced proteome analysis solution leverages cutting-edge deep learning technologies to overcome the most pressing challenges in the field. With unparalleled accuracy, faster insights, and a user-friendly platform, we empower researchers and healthcare professionals to accelerate discovery and deliver impactful outcomes.

→

Real-Time Surgery AI Platform

Developed a real-time surgery AI platform where computer vision is assisting surgeons during surgery. This is redefining the accuracy and success rate of surgery. Top healthcare executives and researchers led and build this industry’s first Surgery AI Platform.

→

Persona-Perfect Style: Wardrobe Recommendations for You

A unique offering from a clothing and accessories ecommerce company. A platform powered by predictive analytics and smart web content strategy to suggest wardrobe style as per persona.

→